Why the study?
Does three-dimensional transthoracic echocardiography improve the diagnosis, management, and prognostication of intrinsic cardiomyopathies compared to traditional two-dimensional transthoracic echocardiography?
Does three-dimensional transthoracic echocardiography improve the diagnosis, management, and prognostication of intrinsic cardiomyopathies compared to traditional two-dimensional transthoracic echocardiography?
Three-dimensional transthoracic echocardiography is increasingly useful and offers advantages over traditional two-dimensional echocardiography for evaluating intrinsic cardiomyopathies.
Cardiomyopathy refers to a set of diseases that are characterized by myocardial dysfunction. Classically, two‐dimensional echocardiography has been used in the diagnosis of these disorders and to help guide their management. Three‐dimensional transthoracic echocardiography is now increasingly being used in the diagnosis, management, and prognostication of intrinsic cardiomyopathies. In this article, we summarize the available data on the use of three‐dimensional transthoracic echocardiography in various forms of intrinsic cardiomyopathy as well as some of its advantages over traditional two‐dimensional transthoracic echocardiography. (Echocardiography 2012;29:76‐87)
No takes yet. Share an insight, caveat, or question.
Hage et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: